These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2971959)

  • 1. [Arterial hypertension, renal function and angiotensin-converting enzyme inhibition].
    Ribstein J; Mourad G; Mimran A
    Presse Med; 1988 Sep; 17(31):1578-82. PubMed ID: 2971959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
    Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal function after administration of angiotensin-converting enzyme inhibitors].
    Waeber B; Burnier M; Nussberger J; Brunner HR
    Schweiz Med Wochenschr; 1987 Sep; 117(37):1359-62. PubMed ID: 3672075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury.
    Jackson B; Johnston CI
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():107-15. PubMed ID: 2674436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
    Hollenberg NK; Swartz SL; Passan DR; Williams GH
    N Engl J Med; 1979 Jul; 301(1):9-12. PubMed ID: 221809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure, angiotensin-converting enzyme (ACE) inhibitors, and the kidney.
    MacGregor GA
    Am J Med; 1992 Apr; 92(4B):20S-27S. PubMed ID: 1580276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition: renal aspect.
    Hollenberg NK
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S40-4. PubMed ID: 2580175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition-induced changes in hippurate renography and renal function in renovascular hypertension.
    Visscher CA; de Zeeuw D; de Jong PE; Piers DA; Beekhuis H; Groothuis GM; Huisman RM
    J Nucl Med; 1996 Mar; 37(3):482-8. PubMed ID: 8772652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension.
    Mimran A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S45-50. PubMed ID: 1382165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment and recovery of the clipped kidney in two kidney, one clip hypertensive rats during and after antihypertensive therapy.
    Gröne HJ; Helmchen U
    Lab Invest; 1986 Jun; 54(6):645-55. PubMed ID: 3012198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
    Götz R; Heidbreder E; Heidland A
    Clin Physiol Biochem; 1990; 8 Suppl 1():25-32. PubMed ID: 2257721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibition and the kidney.
    Hollenberg NK
    Curr Opin Cardiol; 1988; 3(Suppl 1):S19-29. PubMed ID: 11538849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of calcium antagonists and converting enzyme inhibitors on renal function under normal and hypertensive conditions.
    Romero JC; Ruilope LM; Bentley MD; Fiksen-Olsen MJ; Lahera V; Vidal MJ
    Am J Cardiol; 1988 Oct; 62(11):59G-68G. PubMed ID: 3051997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats.
    Palm F; Connors SG; Mendonca M; Welch WJ; Wilcox CS
    Hypertension; 2008 Feb; 51(2):345-51. PubMed ID: 18158356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.